BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Dr. Paula Brown Appointed to Board of Wholly Owned Subsidiary Biocell Laboratories Inc. and Acquires Formulations

  March 4, 2013

   · 

  3 min read
• Business

  Imprimis Pharmaceuticals Out Licenses Its Proprietary IP to ResolutionMD for Cosmeceutical Products

  March 4, 2013

   · 

  3 min read
• Business

  BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration

  March 4, 2013

   · 

  1 min read
• Genetown

  Genzyme Corporation’s Head of Rare Diseases Honored by the Genetic Disease Foundation

  March 4, 2013

   · 

  1 min read
• Business

  Virtua and Alere Inc. Form Alliance for Care Coordination

  March 4, 2013

   · 

  3 min read
• Drug Development

  Targeted Medical Pharma Reports New Data on Red Blood Cell Stimulating Formulation

  March 4, 2013

   · 

  1 min read
• FDA

  Regeneron Pharmaceuticals, Inc. Announces Potential Additional Royalty Stream Related to EU Approval for Ilaris® (canakinumab) in Patients Suffering Acute Gouty Arthritis Attacks Who Cannot Gain Relief From Current Treatments

  March 4, 2013

   · 

  3 min read
• Policy

  FDA Accepts Biogen Idec, Inc. (Massachusetts)'s Biologics License Application for First Long-Lasting Factor IX Therapy for Hemophilia B

  March 4, 2013

   · 

  1 min read
• Biotech Bay

  Ultragenyx Pharmaceuticals to Present at the Cowen and Company 33rd Annual Health Care Conference

  March 4, 2013

   · 

  1 min read
• Genetown

  Abiomed Announces Several Reimbursement Milestones

  March 4, 2013

   · 

  1 min read